Patients can experience diarrhea, nausea, constipation and vomiting
Since tirzepatide engages both pathways at the same time, it suppresses appetite while helping keep insulin in line so blood sugar doesn't spike sharply
Watch for dehydration signs: headaches, dizziness, dark urine, and constipation are all common on GLP-1s and often trace back to not drinking enough between meals
Reconstituted tirzepatide stability with bacteriostatic water is documented at up to 28 days
The 65% trigger Emil Kongshj Larsen, Novo Nordisk's executive vice president of international operations, told analysts on the company's most recent earnings call that once three generic competitors are on the Canadian market, national policy mandates a 65% cut to Novo's list price